This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Teva Pharmaceutical 3.25% 2022-04 EUR

Update! New bond issue: Teva Pharmaceutical (NYSE:TEVA) issued new debt notes (XS1789745137) (144A: XS1789747265) for 700M EUR as of March 7, 2018. Tradable at Euronext Dublin as of April 5, 2018. New tranche for 700M EUR with issue date April 19, 2018. Listed at Frankfurt Stock Exchange and Stuttgart Stock Exchange as of May 30, 2018.

Teva Pharmaceutical Finance NV operates in the Netherlands as a finance subsidiary of Teva Pharmaceutical Industries Limited, an Israeli multinational pharmaceutical company.

IssuerTeva Pharmaceutical Finance
Stock (Group)NYSE:TEVA
Bond TypeCorporate
CategorySenior, Callable
Maturity DateApril 15, 2022
Residual Duration1 year, 4 months, 12 days
CurrencyEUR (Euro)
Coupon TypeFixed Rate
Coupon (Yearly)3.250%
Coupon FrequencySemiannual
Minimum Lot100,000 EUR
Additional Lots1,000 EUR
Issue DateMarch 14, 2018
Issued Amount700,000,000 EUR
Tranche Amount700,000,000 EUR
Issue Price100.000%
Maturity Price100.000%
Home ExchangeDublin
Other ExchangesFrankfurt, Berlin, Stuttgart
Isin 144AXS1789747265 (144A)
Temporary IsinXS1812903828 (exchange)
Issue DocumentationIssue Prospectus
SectorHealth Care
RegionEurope developed

Bonds, Corporate, Health Care, Pharmaceuticals, Europe developed, Netherlands, EUR, Fixed Rate, Income

Next Graubundner Kantonalbank 0.125% 2024-05 CHF